Biomarkers principles in disease have been applied to cancer detection, screening, diagnosis, treatment, and monitoring. Anti-cancer drugs have traditionally been agents that killed both cancer cells and healthy cells. More targeted therapies, on the other hand, have now been developed that can be directed to kill only cancer cells while leaving healthy cells alone. The evaluation of a common biomarker in cancer aids in the development of therapies that target the biomarkers. This can reduce the risk of toxicity while also lowering treatment costs. Genetic studies are useful in cancer research because genetic abnormalities frequently underpin cancer development. As a result, specific DNA or RNA markers may aid in the detection and treatment of specific cancers.
Read More:
https://ext-6049742.livejournal.com/1088.html
Click here for Biomarkers Market Press Release: